Resources We Trust Cleveland Clinic: The New Anti-Obesity Drugs: What You Should Know Mayo Clinic: Pros and Cons of GLP-1 Agonists for Weight Loss Harvard Health: Questions and Answers About the New Anti-Obesity Medications Yale Medicine: Why Your Cardiologist May Prescribe Semaglutide (Wegovy) NewYork-Presbyterian: Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Managing the PCOS Connection Many people asking if they can take these two medications together are doing so because they have PCOS
Broad interest is now focused on the biguanide metformin 37, 38 (see review in the same issue of this topical issue) as well as IR and IGF-1R inhibitors
doi: 10.1007/BF00555510 [DOI] [PubMed] [Google Scholar] 14
Throughout VYVANSE treatment, reassess each patient's risk of abuse, misuse, and addiction and frequently monitor for signs and symptoms of abuse, misuse, and addiction
No insurance plans currently cover retatrutide because it does not have FDA approval
